236 related articles for article (PubMed ID: 26594847)
21. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
Fitton A; Goa KL
Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
[TBL] [Abstract][Full Text] [Related]
23. Cognitive functioning in community dwelling older adults with chronic partial epilepsy.
Martin RC; Griffith HR; Faught E; Gilliam F; Mackey M; Vogtle L
Epilepsia; 2005 Feb; 46(2):298-303. PubMed ID: 15679511
[TBL] [Abstract][Full Text] [Related]
24. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
25. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
[TBL] [Abstract][Full Text] [Related]
26. Changes in seizure severity and quality of life in patients with refractory partial epilepsy.
Sancho J; Iváñez V; Molins A; López Gómez V; Masramón X; Pérez M
Epilepsy Behav; 2010 Nov; 19(3):409-13. PubMed ID: 20855235
[TBL] [Abstract][Full Text] [Related]
27. Quality of life improvement with conversion to lamotrigine monotherapy.
Cramer JA; Hammer AE; Kustra RP
Epilepsy Behav; 2004 Apr; 5(2):224-30. PubMed ID: 15123024
[TBL] [Abstract][Full Text] [Related]
28. [The use of lamotrigine monotherapy in children with newly diagnosed partial epilepsy].
Sołowiej E; Sobaniec W; Kozik A; Ujma-Czapska B
Neurol Neurochir Pol; 2000; 34 Suppl 1():129-41. PubMed ID: 10768153
[TBL] [Abstract][Full Text] [Related]
29. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.
Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448
[TBL] [Abstract][Full Text] [Related]
30. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
31. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
[TBL] [Abstract][Full Text] [Related]
33. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
[TBL] [Abstract][Full Text] [Related]
34. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial.
Ryvlin P; Gilliam FG; Nguyen DK; Colicchio G; Iudice A; Tinuper P; Zamponi N; Aguglia U; Wagner L; Minotti L; Stefan H; Boon P; Sadler M; Benna P; Raman P; Perucca E
Epilepsia; 2014 Jun; 55(6):893-900. PubMed ID: 24754318
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
[TBL] [Abstract][Full Text] [Related]
36. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
Hur YJ
Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
[TBL] [Abstract][Full Text] [Related]
37. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
Hessen E; Lossius MI; Reinvang I; Gjerstad L
Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
[TBL] [Abstract][Full Text] [Related]
38. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam.
Cramer JA; Arrigo C; Van Hammée G; Bromfield EB
Epilepsy Res; 2000 Aug; 41(1):29-38. PubMed ID: 10924866
[TBL] [Abstract][Full Text] [Related]
39. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children.
Zamponi N; Cardinali C
Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256
[TBL] [Abstract][Full Text] [Related]
40. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery.
Elsharkawy AE; Thorbecke R; Ebner A; May TW
Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
